SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE: Form 990, tax year 2019

View the entire original 990 at ProPublica ↗

Organization: SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE (EIN 51-0197108)
Tax period: 2019-07-01 to 2020-06-30
Filed: 2021-05-17
IRS object ID: 202141379349304144
Schema version: 2019v5.1
Source: Download XML · Original 990 at ProPublica

Every field in the e-filed return. Faint text is the IRS element name, for citing.

Return header
Form 990
Schedule A
Schedule B
Schedule C
Schedule D
Schedule F
Schedule G
Schedule J
Schedule K
Schedule M
Schedule O

Return header ReturnHeader

Field	Value	IRS element (for citing)
Return	2021-05-17T11:55:58-05:00	ReturnTs
Tax Period End	2020-06-30	TaxPeriodEndDt

Preparer Firm PreparerFirmGrp

Preparer Firm Name PreparerFirmName

Field	Value	IRS element (for citing)
Business Name Line1	ERNST & YOUNG US LLP	BusinessNameLine1Txt

Preparer US Address PreparerUSAddress

Field	Value	IRS element (for citing)
Address Line1	4365 EXECUTIVE DR STE 1600	AddressLine1Txt
City	SAN DIEGO	CityNm
State Abbreviation	CA	StateAbbreviationCd
ZIP	92121	ZIPCd

Field	Value	IRS element (for citing)
Return Type	990	ReturnTypeCd
Tax Period Begin	2019-07-01	TaxPeriodBeginDt

Filer Filer

Field	Value	IRS element (for citing)
EIN	510197108	EIN

Business Name BusinessName

Field	Value	IRS element (for citing)
Business Name Line1	SANFORD BURNHAM PREBYS MEDICAL DISCOVERY	BusinessNameLine1Txt
Business Name Line2	INSTITUTE	BusinessNameLine2Txt

Field	Value	IRS element (for citing)
In Care Of	% LOUIS COFFMAN	InCareOfNm
Business Name Control	SANF	BusinessNameControlTxt
Phone	8586463100	PhoneNum

US Address USAddress

Field	Value	IRS element (for citing)
Address Line1	10901 NORTH TORREY PINES ROAD	AddressLine1Txt
City	LA JOLLA	CityNm
State Abbreviation	CA	StateAbbreviationCd
ZIP	92037	ZIPCd

Business Officer BusinessOfficerGrp

Field	Value	IRS element (for citing)
Person	LOUIS COFFMAN	PersonNm
Person Title	CAO & CFO	PersonTitleTxt
Phone	8586463100	PhoneNum
Signature	2021-05-17	SignatureDt
Discuss With Paid Preparer	Yes (true)	DiscussWithPaidPreparerInd

Preparer Person PreparerPersonGrp

Field	Value	IRS element (for citing)
Preparer Person	JOCELYNE MILLER	PreparerPersonNm
PTIN	P00634378	PTIN
Phone	8585357200	PhoneNum

Field	Value	IRS element (for citing)
Tax	2019	TaxYr
Build TS	2022-09-23 18:48:47Z	BuildTS

Form 990 IRS990

Field	Value	IRS element (for citing)
Principal Officer	C RANDAL MILLS PHD	PrincipalOfficerNm

US Address USAddress

Field	Value	IRS element (for citing)
Address Line1	10901 NORTH TORREY PINES ROAD	AddressLine1Txt
City	LA JOLLA	CityNm
State Abbreviation	CA	StateAbbreviationCd
ZIP	92037	ZIPCd

Field	Value	IRS element (for citing)
Gross Receipts	$330,130,622	GrossReceiptsAmt
Group Return For Affiliates	false	GroupReturnForAffiliatesInd
Organization501c3	Yes (X)	Organization501c3Ind
Website Address	WWW.SBPDISCOVERY.ORG	WebsiteAddressTxt
Type Of Organization Corp	Yes (X)	TypeOfOrganizationCorpInd
Formation	1976	FormationYr
Legal Domicile State	CA	LegalDomicileStateCd
Activity Or Mission	SEE SCHEDULE O	ActivityOrMissionDesc
Voting Members Governing Body	17	VotingMembersGoverningBodyCnt
Voting Members Independent	16	VotingMembersIndependentCnt
Total Employee	779	TotalEmployeeCnt
Total Volunteers	19	TotalVolunteersCnt
Total Gross UBI	$2,023,074	TotalGrossUBIAmt
Net Unrelated Bus Txbl Incm	$0	NetUnrelatedBusTxblIncmAmt
PY Contributions Grants	$108,300,329	PYContributionsGrantsAmt
CY Contributions Grants	$100,963,692	CYContributionsGrantsAmt
PY Program Service Revenue	$799,803	PYProgramServiceRevenueAmt
CY Program Service Revenue	$643,286	CYProgramServiceRevenueAmt
PY Investment Income	$11,593,574	PYInvestmentIncomeAmt
CY Investment Income	$12,481,799	CYInvestmentIncomeAmt
PY Other Revenue	$2,262,753	PYOtherRevenueAmt
CY Other Revenue	$2,641,626	CYOtherRevenueAmt
PY Total Revenue	$122,956,459	PYTotalRevenueAmt
CY Total Revenue	$116,730,403	CYTotalRevenueAmt
PY Grants And Similar Paid	$0	PYGrantsAndSimilarPaidAmt
CY Grants And Similar Paid	$0	CYGrantsAndSimilarPaidAmt
PY Benefits Paid To Members	$0	PYBenefitsPaidToMembersAmt
CY Benefits Paid To Members	$0	CYBenefitsPaidToMembersAmt
PY Salaries Comp Emp Bnft Paid	$65,811,734	PYSalariesCompEmpBnftPaidAmt
CY Salaries Comp Emp Bnft Paid	$62,755,446	CYSalariesCompEmpBnftPaidAmt
PY Total Prof Fndrsng Expns	$0	PYTotalProfFndrsngExpnsAmt
CY Total Prof Fndrsng Expns	$0	CYTotalProfFndrsngExpnsAmt
CY Total Fundraising Expense	$1,437,805	CYTotalFundraisingExpenseAmt
PY Other Expenses	$120,469,124	PYOtherExpensesAmt
CY Other Expenses	$49,892,483	CYOtherExpensesAmt
PY Total Expenses	$186,280,858	PYTotalExpensesAmt
CY Total Expenses	$112,647,929	CYTotalExpensesAmt
PY Revenues Less Expenses	-$63,324,399	PYRevenuesLessExpensesAmt
CY Revenues Less Expenses	$4,082,474	CYRevenuesLessExpensesAmt
Total Assets BOY	$338,796,799	TotalAssetsBOYAmt
Total Assets EOY	$307,274,683	TotalAssetsEOYAmt
Total Liabilities BOY	$123,189,379	TotalLiabilitiesBOYAmt
Total Liabilities EOY	$93,150,241	TotalLiabilitiesEOYAmt
Net Assets Or Fund Balances BOY	$215,607,420	NetAssetsOrFundBalancesBOYAmt
Net Assets Or Fund Balances EOY	$214,124,442	NetAssetsOrFundBalancesEOYAmt
Info In Schedule O Part III	Yes (X)	InfoInScheduleOPartIIIInd
Mission	SEE SCHEDULE O	MissionDesc
Significant New Program Srvc	false	SignificantNewProgramSrvcInd
Significant Change	false	SignificantChangeInd
Expense	$92,098,609	ExpenseAmt
Grant	$0	GrantAmt
Revenue	$757,474	RevenueAmt
Desc	SEE SCHEDULE O	Desc
Total Program Service Expenses	$92,098,609	TotalProgramServiceExpensesAmt
Described In Section501c3	Yes (true)	DescribedInSection501c3Ind
Schedule B Required	Yes (true)	ScheduleBRequiredInd
Political Campaign Acty	false	PoliticalCampaignActyInd
Lobbying Activities	Yes (true)	LobbyingActivitiesInd
Subject To Proxy Tax	false	SubjectToProxyTaxInd
Donor Advised Fund	false	DonorAdvisedFundInd
Conservation Easements	false	ConservationEasementsInd
Collections Of Art	false	CollectionsOfArtInd
Credit Counseling	false	CreditCounselingInd
Donor Rstr Or Quasi Endowments	Yes (true)	DonorRstrOrQuasiEndowmentsInd
Report Land Building Equipment	Yes (true)	ReportLandBuildingEquipmentInd
Report Investments Other Sec	Yes (true)	ReportInvestmentsOtherSecInd
Report Program Related Invst	false	ReportProgramRelatedInvstInd
Report Other Assets	false	ReportOtherAssetsInd
Report Other Liabilities	false	ReportOtherLiabilitiesInd
Include FIN48 Footnote	Yes (true)	IncludeFIN48FootnoteInd
Independent Audit Fincl Stmt	Yes (true)	IndependentAuditFinclStmtInd
Consolidated Audit Fincl Stmt	false	ConsolidatedAuditFinclStmtInd
School Operating	false	SchoolOperatingInd
Foreign Office	Yes (true)	ForeignOfficeInd
Foreign Activities	Yes (true)	ForeignActivitiesInd
More Than5000 K To Org	false	MoreThan5000KToOrgInd
More Than5000 K To Individuals	false	MoreThan5000KToIndividualsInd
Professional Fundraising	false	ProfessionalFundraisingInd
Fundraising Activities	Yes (true)	FundraisingActivitiesInd
Gaming Activities	false	GamingActivitiesInd
Operate Hospital	false	OperateHospitalInd
Grants To Organizations	false	GrantsToOrganizationsInd
Grants To Individuals	false	GrantsToIndividualsInd
Schedule J Required	Yes (true)	ScheduleJRequiredInd
Tax Exempt Bonds	Yes (true)	TaxExemptBondsInd
Invest Tax Exempt Bonds	false	InvestTaxExemptBondsInd
Escrow Account	false	EscrowAccountInd
On Behalf Of Issuer	false	OnBehalfOfIssuerInd
Engaged In Excess Benefit Trans	false	EngagedInExcessBenefitTransInd
PY Excess Benefit Trans	false	PYExcessBenefitTransInd
Loan Outstanding	false	LoanOutstandingInd
Grant To Related Person	false	GrantToRelatedPersonInd
Business Rln With Org Mem	false	BusinessRlnWithOrgMemInd
Business Rln With Fam Mem	false	BusinessRlnWithFamMemInd
Business Rln With35 Ctrl Ent	false	BusinessRlnWith35CtrlEntInd
Deductible Non Cash Contri	Yes (true)	DeductibleNonCashContriInd
Deductible Art Contribution	false	DeductibleArtContributionInd
Terminate Operations	false	TerminateOperationsInd
Partial Liquidation	false	PartialLiquidationInd
Disregarded Entity	false	DisregardedEntityInd
Related Entity	false	RelatedEntityInd
Related Organization Ctrl Ent	false	RelatedOrganizationCtrlEntInd
Trnsfr Exmpt Non Chrtbl Rltd Org	false	TrnsfrExmptNonChrtblRltdOrgInd
Activities Conducted Prtshp	false	ActivitiesConductedPrtshpInd
Schedule O Required	Yes (true)	ScheduleORequiredInd
IRP Document	183	IRPDocumentCnt
IRP Document W2 G	0	IRPDocumentW2GCnt
Backup Wthld Compliance	Yes (true)	BackupWthldComplianceInd
Employee	779	EmployeeCnt
Employment Tax Returns Filed	Yes (true)	EmploymentTaxReturnsFiledInd
Unrelated Bus Incm Over Limit	Yes (true)	UnrelatedBusIncmOverLimitInd
Form990 T Filed	Yes (true)	Form990TFiledInd
Foreign Financial Account	false	ForeignFinancialAccountInd
Prohibited Tax Shelter Trans	false	ProhibitedTaxShelterTransInd
Taxable Party Notification	false	TaxablePartyNotificationInd
Nondeductible Contributions	false	NondeductibleContributionsInd
Quid Pro Quo Contributions	Yes (true)	QuidProQuoContributionsInd
Quid Pro Quo Contri Discl	Yes (true)	QuidProQuoContriDisclInd
Form8282 Property Disposed Of	false	Form8282PropertyDisposedOfInd
Rcv Fnds To Pay Prsnl Bnft Cntrct	false	RcvFndsToPayPrsnlBnftCntrctInd
Pay Premiums Prsnl Bnft Cntrct	false	PayPremiumsPrsnlBnftCntrctInd
Indoor Tanning Services	false	IndoorTanningServicesInd
Subj To Tax Rmnrtn Ex Prcht Pymt	false	SubjToTaxRmnrtnExPrchtPymtInd
Subject To Excs Tax Net Invst Inc	false	SubjectToExcsTaxNetInvstIncInd
Info In Schedule O Part VI	Yes (X)	InfoInScheduleOPartVIInd
Governing Body Voting Members	17	GoverningBodyVotingMembersCnt
Independent Voting Member	16	IndependentVotingMemberCnt
Family Or Business Rln	false	FamilyOrBusinessRlnInd
Delegation Of Mgmt Duties	false	DelegationOfMgmtDutiesInd
Change To Org Documents	false	ChangeToOrgDocumentsInd
Material Diversion Or Misuse	false	MaterialDiversionOrMisuseInd
Members Or Stockholders	false	MembersOrStockholdersInd
Election Of Board Members	false	ElectionOfBoardMembersInd
Decisions Subject To Approva	false	DecisionsSubjectToApprovaInd
Minutes Of Governing Body	Yes (true)	MinutesOfGoverningBodyInd
Minutes Of Committees	Yes (true)	MinutesOfCommitteesInd
Officer Mailing Address	false	OfficerMailingAddressInd
Local Chapters	false	LocalChaptersInd
Form990 Provided To Gvrn Body	Yes (true)	Form990ProvidedToGvrnBodyInd
Conflict Of Interest Policy	Yes (true)	ConflictOfInterestPolicyInd
Annual Disclosure Covered Prsn	Yes (true)	AnnualDisclosureCoveredPrsnInd
Regular Monitoring Enfrc	Yes (true)	RegularMonitoringEnfrcInd
Whistleblower Policy	Yes (true)	WhistleblowerPolicyInd
Document Retention Policy	Yes (true)	DocumentRetentionPolicyInd
Compensation Process CEO	Yes (true)	CompensationProcessCEOInd
Compensation Process Other	Yes (true)	CompensationProcessOtherInd
Investment In Joint Venture	false	InvestmentInJointVentureInd
States Where Copy Of Return Is Fld	AL	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	AK	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	AR	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	CA	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	CO	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	CT	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	DC	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	FL	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	GA	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	IL	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	KS	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	KY	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	ME	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	MD	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	MA	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	MI	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	MN	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	MS	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	NH	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	NJ	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	NM	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	NY	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	NC	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	ND	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	OH	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	OK	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	OR	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	PA	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	RI	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	SC	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	TN	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	UT	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	VA	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	WA	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	WV	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	WI	StatesWhereCopyOfReturnIsFldCd
Upon Request	Yes (X)	UponRequestInd

Books In Care Of Detail BooksInCareOfDetail

Field	Value	IRS element (for citing)
Person	LOUIS COFFMAN	PersonNm
Phone	8586463100	PhoneNum

US Address USAddress

Field	Value	IRS element (for citing)
Address Line1	10901 NORTH TORREY PINES RD	AddressLine1Txt
City	LA JOLLA	CityNm
State Abbreviation	CA	StateAbbreviationCd
ZIP	92037	ZIPCd

Form990 Part VII Section A Form990PartVIISectionAGrp (26 entries)

TitleTitleTxt	Average Hours Per WeekAverageHoursPerWeekRt	Average Hours Per Week Rltd OrgAverageHoursPerWeekRltdOrgRt	Individual Trustee Or DirectorIndividualTrusteeOrDirectorInd	OfficerOfficerInd	Reportable Comp From OrgReportableCompFromOrgAmt	Reportable Comp From Rltd OrgReportableCompFromRltdOrgAmt	Other CompensationOtherCompensationAmt	Highest Compensated EmployeeHighestCompensatedEmployeeInd
KRISTIINA VUORI MD PHD
PRESIDENT	50.0	0.0	Yes (X)	Yes (X)	$1,022,617	$0	$350,424
GARTH POWIS PHD
CENTER DIRECTOR	50.0	0.0			$504,532	$0	$53,042	Yes (X)
MICHAEL JACKSON PHD
DRUG DISCOVERY & DEV, SR VP	50.0	1.0			$432,356	$0	$58,766	Yes (X)
CARL WARE PHD
CENTER DIRECTOR, IIDC	50.0	1.0			$437,966	$0	$52,965	Yes (X)
JORGE MOSCAT PHD
PROGRAM DIRECTOR	50.0	1.0			$431,058	$0	$55,855	Yes (X)
LOUIS COFFMAN
CAO & CFO	50.0	0.0		Yes (X)	$434,723	$0	$40,656
ZE'EV RONAI PHD
PROGRAM DIRECTOR	50.0	0.0			$383,277	$0	$65,401	Yes (X)
DOUGLAS OBENSHAIN
TRUSTEE	1.0	0.0	Yes (X)		$0	$0	$0
DAVID DOWN
TRUSTEE	1.0	0.0	Yes (X)		$0	$0	$0
WILLIAM GERHART
VICE CHAIRMAN	1.0	0.0	Yes (X)	Yes (X)	$0	$0	$0
STUART TANZ
TRUSTEE	1.0	0.0	Yes (X)		$0	$0	$0
JAMES JARDON
TRUSTEE	1.0	0.0	Yes (X)		$0	$0	$0
JAMES MYERS
TRUSTEE	1.0	0.0	Yes (X)		$0	$0	$0
KAZUMI SHIOSAKI PHD
TRUSTEE	1.0	0.0	Yes (X)		$0	$0	$0
PETER SEIDLER
TRUSTEE (PART YEAR)	1.0	0.0	Yes (X)		$0	$0	$0
DAN EPSTEIN
TRUSTEE	1.0	0.0	Yes (X)		$0	$0	$0
WILLIAM ROPER
TRUSTEE	1.0	0.0	Yes (X)		$0	$0	$0
MATTHEW BROWNE
TRUSTEE	1.0	0.0	Yes (X)		$0	$0	$0
DAVID SZEKERES
TRUSTEE	1.0	0.0	Yes (X)		$0	$0	$0
KAREN HAYNES PHD
TRUSTEE	1.0	0.0	Yes (X)		$0	$0	$0
DONALD KERNS PHD
TRUSTEE	1.0	0.0	Yes (X)		$0	$0	$0
JEANNE HERBERGER
TRUSTEE (PART YEAR)	1.0	0.0	Yes (X)		$0	$0	$0
ANNA BARKER PHD
TRUSTEE	1.0	0.0	Yes (X)		$0	$0	$0
HENRY NORDOFF
TRUSTEE	1.0	0.0	Yes (X)		$0	$0	$0
JAMES BLAIR PHD
CHAIRMAN	1.0	0.0	Yes (X)	Yes (X)	$0	$0	$0
KNOX BELL
CORPORATE SECRETARY	2.0	0.0		Yes (X)	$0	$0	$0

Field	Value	IRS element (for citing)
Total Reportable Comp From Org	$3,646,529	TotalReportableCompFromOrgAmt
Tot Reportable Comp Rltd Org	$0	TotReportableCompRltdOrgAmt
Total Other Compensation	$677,109	TotalOtherCompensationAmt
Indiv Rcvd Greater Than100 K	119	IndivRcvdGreaterThan100KCnt
Former Ofcr Employees Listed	false	FormerOfcrEmployeesListedInd
Total Comp Greater Than150 K	Yes (true)	TotalCompGreaterThan150KInd
Compensation From Other Srcs	false	CompensationFromOtherSrcsInd

Contractor Compensation ContractorCompensationGrp (5 entries)

Address Line1ContractorAddress/USAddress/AddressLine1Txt	CityContractorAddress/USAddress/CityNm	State AbbreviationContractorAddress/USAddress/StateAbbreviationCd	ZIPContractorAddress/USAddress/ZIPCd	ServicesServicesDesc	CompensationCompensationAmt
DELOITTE TOUCHE LLP
655 WEST BROADWAY SUITE 400	SAN DIEGO	CA	92101	AUDIT SERVICES	$384,891
WILSON SONSINI GOODRICH
PO BOX 742866	LOS ANGELES	CA	90074	LEGAL SERVICES	$258,150
STEALTH PARTNER GROUP
18940 NORTH PIMA ROAD SUITE 210	SCOTTSDALE	AZ	85255	ADMIN SERVICES	$190,745
DLA PIPER LLP
PO BOX 64029	BALTIMORE	MD	21264	LEGAL SERVICES	$180,078
CLARIVATE ANALYTICS LLC
PO BOX 3772	CAROL STREAM	IL	60132	DATA CONSULTANTS	$178,713

Field	Value	IRS element (for citing)
Cntrct Rcvd Greater Than100 K	7	CntrctRcvdGreaterThan100KCnt
Fundraising	$307,815	FundraisingAmt
Government Grants	$65,458,505	GovernmentGrantsAmt
All Other Contributions	$35,197,372	AllOtherContributionsAmt
Noncash Contributions	$55,580	NoncashContributionsAmt
Total Contributions	$100,963,692	TotalContributionsAmt

Program Service Revenue ProgramServiceRevenueGrp

Field	Value	IRS element (for citing)
Desc	SHARED SERVICES REVENUE	Desc
Business	541990	BusinessCd
Total Revenue Column	$643,286	TotalRevenueColumnAmt
Related Or Exempt Func Income	$643,286	RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue	$0	UnrelatedBusinessRevenueAmt
Exclusion	$0	ExclusionAmt

Field	Value	IRS element (for citing)
Total Program Service Revenue	$643,286	TotalProgramServiceRevenueAmt

Investment Income InvestmentIncomeGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$3,446,814	TotalRevenueColumnAmt
Exclusion	$3,446,814	ExclusionAmt

Incm From Invest Bond Proceeds IncmFromInvestBondProceedsGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$0	TotalRevenueColumnAmt
Exclusion	$0	ExclusionAmt

Royalties Revenue RoyaltiesRevenueGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$577,664	TotalRevenueColumnAmt
Exclusion	$577,664	ExclusionAmt

Gross Rents GrossRentsGrp

Field	Value	IRS element (for citing)
Real	$59,600	RealAmt

Rental Income Or Loss RentalIncomeOrLossGrp

Field	Value	IRS element (for citing)
Real	$59,600	RealAmt
Personal	$0	PersonalAmt

Net Rental Income Or Loss NetRentalIncomeOrLossGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$59,600	TotalRevenueColumnAmt
Exclusion	$59,600	ExclusionAmt

Gross Amount Sales Assets GrossAmountSalesAssetsGrp

Field	Value	IRS element (for citing)
Securities	$222,275,304	SecuritiesAmt

Less Cost Oth Basis Sales Expnss LessCostOthBasisSalesExpnssGrp

Field	Value	IRS element (for citing)
Securities	$213,240,319	SecuritiesAmt

Gain Or Loss GainOrLossGrp

Field	Value	IRS element (for citing)
Securities	$9,034,985	SecuritiesAmt

Net Gain Or Loss Investments NetGainOrLossInvestmentsGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$9,034,985	TotalRevenueColumnAmt
Exclusion	$9,034,985	ExclusionAmt

Field	Value	IRS element (for citing)
Fundraising Gross Income	$27,000	FundraisingGrossIncomeAmt
Contri Rpt Fundraising Event	$307,815	ContriRptFundraisingEventAmt
Fundraising Direct Expenses	$159,900	FundraisingDirectExpensesAmt

Net Incm From Fundraising Evt NetIncmFromFundraisingEvtGrp

Field	Value	IRS element (for citing)
Total Revenue Column	-$132,900	TotalRevenueColumnAmt
Exclusion	-$132,900	ExclusionAmt

Field	Value	IRS element (for citing)
Gaming Gross Income	$0	GamingGrossIncomeAmt
Gaming Direct Expenses	$0	GamingDirectExpensesAmt

Net Income From Gaming NetIncomeFromGamingGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$0	TotalRevenueColumnAmt

Field	Value	IRS element (for citing)
Gross Sales Of Inventory	$0	GrossSalesOfInventoryAmt
Cost Of Goods Sold	$0	CostOfGoodsSoldAmt

Net Income Or Loss NetIncomeOrLossGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$0	TotalRevenueColumnAmt

Other Revenue Misc OtherRevenueMiscGrp (3 entries)

DescDesc	BusinessBusinessCd	Total Revenue ColumnTotalRevenueColumnAmt	Related Or Exempt Func IncomeRelatedOrExemptFuncIncomeAmt	Unrelated Business RevenueUnrelatedBusinessRevenueAmt	ExclusionExclusionAmt
Research	541700	$2,023,074	$0	$2,023,074	$0
OTHER RESEARCH SUPPORT	541990	$55,844	$55,844	$0	$0
SALE OF REAGENTS	541990	$28,844	$28,844	$0	$0

Miscellaneous Revenue MiscellaneousRevenueGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$29,500	TotalRevenueColumnAmt
Related Or Exempt Func Income	$29,500	RelatedOrExemptFuncIncomeAmt
Exclusion	$0	ExclusionAmt

Field	Value	IRS element (for citing)
Other Revenue Total	$2,137,262	OtherRevenueTotalAmt

Total Revenue TotalRevenueGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$116,730,403	TotalRevenueColumnAmt
Related Or Exempt Func Income	$757,474	RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue	$2,023,074	UnrelatedBusinessRevenueAmt
Exclusion	$12,986,163	ExclusionAmt

Grants To Domestic Orgs GrantsToDomesticOrgsGrp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt
Program Services	$0	ProgramServicesAmt

Grants To Domestic Individuals GrantsToDomesticIndividualsGrp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt
Program Services	$0	ProgramServicesAmt

Foreign Grants ForeignGrantsGrp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt
Program Services	$0	ProgramServicesAmt

Benefits To Members BenefitsToMembersGrp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt
Program Services	$0	ProgramServicesAmt

Comp Current Ofcr Directors CompCurrentOfcrDirectorsGrp

Field	Value	IRS element (for citing)
Total	$1,732,086	TotalAmt
Program Services	$154,502	ProgramServicesAmt
Management And General	$1,577,584	ManagementAndGeneralAmt
Fundraising	$0	FundraisingAmt

Comp Disqual Persons CompDisqualPersonsGrp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt
Program Services	$0	ProgramServicesAmt
Management And General	$0	ManagementAndGeneralAmt
Fundraising	$0	FundraisingAmt

Other Salaries And Wages OtherSalariesAndWagesGrp

Field	Value	IRS element (for citing)
Total	$47,298,550	TotalAmt
Program Services	$37,613,090	ProgramServicesAmt
Management And General	$8,872,115	ManagementAndGeneralAmt
Fundraising	$813,345	FundraisingAmt

Pension Plan Contributions PensionPlanContributionsGrp

Field	Value	IRS element (for citing)
Total	$3,233,587	TotalAmt
Program Services	$2,496,251	ProgramServicesAmt
Management And General	$681,134	ManagementAndGeneralAmt
Fundraising	$56,202	FundraisingAmt

Other Employee Benefits OtherEmployeeBenefitsGrp

Field	Value	IRS element (for citing)
Total	$7,516,566	TotalAmt
Program Services	$5,939,878	ProgramServicesAmt
Management And General	$1,480,539	ManagementAndGeneralAmt
Fundraising	$96,149	FundraisingAmt

Payroll Taxes PayrollTaxesGrp

Field	Value	IRS element (for citing)
Total	$2,974,657	TotalAmt
Program Services	$2,241,787	ProgramServicesAmt
Management And General	$680,054	ManagementAndGeneralAmt
Fundraising	$52,816	FundraisingAmt

Fees For Services Management FeesForServicesManagementGrp

Field	Value	IRS element (for citing)
Total	$1,193,907	TotalAmt
Program Services	$152,805	ProgramServicesAmt
Management And General	$947,216	ManagementAndGeneralAmt
Fundraising	$93,886	FundraisingAmt

Fees For Services Legal FeesForServicesLegalGrp

Field	Value	IRS element (for citing)
Total	$481,077	TotalAmt
Program Services	$38,648	ProgramServicesAmt
Management And General	$442,429	ManagementAndGeneralAmt
Fundraising	$0	FundraisingAmt

Fees For Services Accounting FeesForServicesAccountingGrp

Field	Value	IRS element (for citing)
Total	$348,063	TotalAmt
Program Services	$0	ProgramServicesAmt
Management And General	$348,063	ManagementAndGeneralAmt
Fundraising	$0	FundraisingAmt

Fees For Services Lobbying FeesForServicesLobbyingGrp

Field	Value	IRS element (for citing)
Total	$1,500	TotalAmt
Program Services	$0	ProgramServicesAmt
Management And General	$1,500	ManagementAndGeneralAmt
Fundraising	$0	FundraisingAmt

Fees For Services Prof Fundraising FeesForServicesProfFundraising

Field	Value	IRS element (for citing)
Total	$0	TotalAmt
Fundraising	$0	FundraisingAmt

Fees For Srvc Invst Mgmnt Fees FeesForSrvcInvstMgmntFeesGrp

Field	Value	IRS element (for citing)
Total	$628,171	TotalAmt
Program Services	$0	ProgramServicesAmt
Management And General	$628,171	ManagementAndGeneralAmt
Fundraising	$0	FundraisingAmt

Fees For Services Other FeesForServicesOtherGrp

Field	Value	IRS element (for citing)
Total	$904,054	TotalAmt
Program Services	$634,330	ProgramServicesAmt
Management And General	$264,443	ManagementAndGeneralAmt
Fundraising	$5,281	FundraisingAmt

Advertising AdvertisingGrp

Field	Value	IRS element (for citing)
Total	$12,502	TotalAmt
Program Services	$0	ProgramServicesAmt
Management And General	$12,502	ManagementAndGeneralAmt
Fundraising	$0	FundraisingAmt

Office Expenses OfficeExpensesGrp

Field	Value	IRS element (for citing)
Total	$5,649,705	TotalAmt
Program Services	$4,967,362	ProgramServicesAmt
Management And General	$631,083	ManagementAndGeneralAmt
Fundraising	$51,260	FundraisingAmt

Information Technology InformationTechnologyGrp

Field	Value	IRS element (for citing)
Total	$1,250,113	TotalAmt
Program Services	$920,349	ProgramServicesAmt
Management And General	$299,493	ManagementAndGeneralAmt
Fundraising	$30,271	FundraisingAmt

Royalties RoyaltiesGrp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt
Program Services	$0	ProgramServicesAmt
Management And General	$0	ManagementAndGeneralAmt
Fundraising	$0	FundraisingAmt

Occupancy OccupancyGrp

Field	Value	IRS element (for citing)
Total	$10,985,009	TotalAmt
Program Services	$10,013,170	ProgramServicesAmt
Management And General	$903,696	ManagementAndGeneralAmt
Fundraising	$68,143	FundraisingAmt

Travel TravelGrp

Field	Value	IRS element (for citing)
Total	$298,833	TotalAmt
Program Services	$261,466	ProgramServicesAmt
Management And General	$35,489	ManagementAndGeneralAmt
Fundraising	$1,878	FundraisingAmt

Pymt Travel Entrtnmnt Pub Ofcl PymtTravelEntrtnmntPubOfclGrp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt
Program Services	$0	ProgramServicesAmt
Management And General	$0	ManagementAndGeneralAmt
Fundraising	$0	FundraisingAmt

Conferences Meetings ConferencesMeetingsGrp

Field	Value	IRS element (for citing)
Total	$928,370	TotalAmt
Program Services	$672,391	ProgramServicesAmt
Management And General	$247,820	ManagementAndGeneralAmt
Fundraising	$8,159	FundraisingAmt

Interest InterestGrp

Field	Value	IRS element (for citing)
Total	$1,778,605	TotalAmt
Program Services	$1,622,088	ProgramServicesAmt
Management And General	$145,490	ManagementAndGeneralAmt
Fundraising	$11,027	FundraisingAmt

Payments To Affiliates PaymentsToAffiliatesGrp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt
Program Services	$0	ProgramServicesAmt
Management And General	$0	ManagementAndGeneralAmt
Fundraising	$0	FundraisingAmt

Depreciation Depletion DepreciationDepletionGrp

Field	Value	IRS element (for citing)
Total	$7,050,756	TotalAmt
Program Services	$6,430,289	ProgramServicesAmt
Management And General	$576,752	ManagementAndGeneralAmt
Fundraising	$43,715	FundraisingAmt

Insurance InsuranceGrp

Field	Value	IRS element (for citing)
Total	$184,870	TotalAmt
Program Services	$0	ProgramServicesAmt
Management And General	$184,870	ManagementAndGeneralAmt
Fundraising	$0	FundraisingAmt

Other Expenses OtherExpensesGrp (4 entries)

DescDesc	TotalTotalAmt	Program ServicesProgramServicesAmt	Management And GeneralManagementAndGeneralAmt	FundraisingFundraisingAmt
RESEARCH SUPPLIES & SVCS	$9,195,443	$9,195,443	$0	$0
Scientific collaborations	$8,532,168	$8,532,168	$0	$0
TUITION FEES	$116,358	$116,358	$0	$0
BAD DEBT	$58,322	$0	$58,322	$0

All Other Expenses AllOtherExpensesGrp

Field	Value	IRS element (for citing)
Total	$294,657	TotalAmt
Program Services	$96,234	ProgramServicesAmt
Management And General	$92,750	ManagementAndGeneralAmt
Fundraising	$105,673	FundraisingAmt

Total Functional Expenses TotalFunctionalExpensesGrp

Field	Value	IRS element (for citing)
Total	$112,647,929	TotalAmt
Program Services	$92,098,609	ProgramServicesAmt
Management And General	$19,111,515	ManagementAndGeneralAmt
Fundraising	$1,437,805	FundraisingAmt

Total Joint Costs TotalJointCostsGrp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt

Cash Non Interest Bearing CashNonInterestBearingGrp

Field	Value	IRS element (for citing)
BOY	$8,780,651	BOYAmt
EOY	$8,063,493	EOYAmt

Savings And Temp Cash Invst SavingsAndTempCashInvstGrp

Field	Value	IRS element (for citing)
BOY	$2,469	BOYAmt
EOY	$3,899	EOYAmt

Pledges And Grants Receivable PledgesAndGrantsReceivableGrp

Field	Value	IRS element (for citing)
BOY	$11,771,097	BOYAmt
EOY	$5,921,294	EOYAmt

Accounts Receivable AccountsReceivableGrp

Field	Value	IRS element (for citing)
BOY	$470,995	BOYAmt
EOY	$416,137	EOYAmt

Receivables From Officers Etc ReceivablesFromOfficersEtcGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$0	EOYAmt

Rcvbl From Disqualified Prsn RcvblFromDisqualifiedPrsnGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$0	EOYAmt

Oth Notes Loans Receivable Net OthNotesLoansReceivableNetGrp

Field	Value	IRS element (for citing)
BOY	$377,300	BOYAmt
EOY	$189,635	EOYAmt

Inventories For Sale Or Use InventoriesForSaleOrUseGrp

Field	Value	IRS element (for citing)
BOY	$45,516	BOYAmt
EOY	$18,229	EOYAmt

Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp

Field	Value	IRS element (for citing)
BOY	$7,961,896	BOYAmt
EOY	$8,256,177	EOYAmt

Field	Value	IRS element (for citing)
Land Bldg Equip Cost Or Other Bss	$162,944,495	LandBldgEquipCostOrOtherBssAmt
Land Bldg Equip Accum Deprec	$109,551,937	LandBldgEquipAccumDeprecAmt

Land Bldg Equip Basis Net LandBldgEquipBasisNetGrp

Field	Value	IRS element (for citing)
BOY	$57,111,231	BOYAmt
EOY	$53,392,558	EOYAmt

Investments Pub Traded Sec InvestmentsPubTradedSecGrp

Field	Value	IRS element (for citing)
BOY	$218,451,769	BOYAmt
EOY	$202,465,901	EOYAmt

Investments Other Securities InvestmentsOtherSecuritiesGrp

Field	Value	IRS element (for citing)
BOY	$33,823,875	BOYAmt
EOY	$28,547,360	EOYAmt

Investments Program Related InvestmentsProgramRelatedGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$0	EOYAmt

Intangible Assets IntangibleAssetsGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$0	EOYAmt

Other Assets Total OtherAssetsTotalGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$0	EOYAmt

Total Assets TotalAssetsGrp

Field	Value	IRS element (for citing)
BOY	$338,796,799	BOYAmt
EOY	$307,274,683	EOYAmt

Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp

Field	Value	IRS element (for citing)
BOY	$15,973,902	BOYAmt
EOY	$12,191,460	EOYAmt

Grants Payable GrantsPayableGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$0	EOYAmt

Deferred Revenue DeferredRevenueGrp

Field	Value	IRS element (for citing)
BOY	$52,727,813	BOYAmt
EOY	$30,022,951	EOYAmt

Tax Exempt Bond Liabilities TaxExemptBondLiabilitiesGrp

Field	Value	IRS element (for citing)
BOY	$54,487,664	BOYAmt
EOY	$50,935,830	EOYAmt

Escrow Account Liability EscrowAccountLiabilityGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$0	EOYAmt

Loans From Officers Directors LoansFromOfficersDirectorsGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$0	EOYAmt

Mortg Notes Pybl Scrd Invst Prop MortgNotesPyblScrdInvstPropGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$0	EOYAmt

Unsecured Notes Loans Payable UnsecuredNotesLoansPayableGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$0	EOYAmt

Other Liabilities OtherLiabilitiesGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$0	EOYAmt

Total Liabilities TotalLiabilitiesGrp

Field	Value	IRS element (for citing)
BOY	$123,189,379	BOYAmt
EOY	$93,150,241	EOYAmt

Field	Value	IRS element (for citing)
Organization Follows FASB117	Yes (X)	OrganizationFollowsFASB117Ind

No Donor Restriction Net Assets NoDonorRestrictionNetAssetsGrp

Field	Value	IRS element (for citing)
BOY	$184,566,051	BOYAmt
EOY	$184,924,802	EOYAmt

Donor Restriction Net Assets DonorRestrictionNetAssetsGrp

Field	Value	IRS element (for citing)
BOY	$31,041,369	BOYAmt
EOY	$29,199,640	EOYAmt

Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp

Field	Value	IRS element (for citing)
BOY	$215,607,420	BOYAmt
EOY	$214,124,442	EOYAmt

Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp

Field	Value	IRS element (for citing)
BOY	$338,796,799	BOYAmt
EOY	$307,274,683	EOYAmt

Field	Value	IRS element (for citing)
Reconcilation Revenue Expnss	$4,082,474	ReconcilationRevenueExpnssAmt
Net Unrlzd Gains Losses Invst	-$5,565,452	NetUnrlzdGainsLossesInvstAmt
Donated Services And Use Fclts	$0	DonatedServicesAndUseFcltsAmt
Prior Period Adjustments	$0	PriorPeriodAdjustmentsAmt
Method Of Accounting Accrual	Yes (X)	MethodOfAccountingAccrualInd
Accountant Compile Or Review	false	AccountantCompileOrReviewInd
FS Audited	Yes (true)	FSAuditedInd

FS Audited Basis FSAuditedBasisGrp

Field	Value	IRS element (for citing)
Separate Basis Fincl Stmt	Yes (X)	SeparateBasisFinclStmtInd

Field	Value	IRS element (for citing)
Audit Committee	Yes (true)	AuditCommitteeInd
Federal Grant Audit Required	Yes (true)	FederalGrantAuditRequiredInd
Federal Grant Audit Performed	Yes (true)	FederalGrantAuditPerformedInd

Schedule A IRS990ScheduleA

Field	Value	IRS element (for citing)
Public Organization170	Yes (X)	PublicOrganization170Ind

Gifts Grants Contri Rcvd170 GiftsGrantsContriRcvd170Grp

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	$112,703,072	CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years	$121,777,889	CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years	$113,630,164	CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year	$108,300,329	CurrentTaxYearMinus1YearAmt
Current Tax Year	$100,963,692	CurrentTaxYearAmt
Total	$557,375,146	TotalAmt

Tax Rev Levied Orgnztnl Bnft170 TaxRevLeviedOrgnztnlBnft170Grp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt

Govt Furn Srvc Fclts Vl170 GovtFurnSrvcFcltsVl170Grp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt

Total Calendar Year170 TotalCalendarYear170Grp

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	$112,703,072	CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years	$121,777,889	CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years	$113,630,164	CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year	$108,300,329	CurrentTaxYearMinus1YearAmt
Current Tax Year	$100,963,692	CurrentTaxYearAmt
Total	$557,375,146	TotalAmt

Field	Value	IRS element (for citing)
Substantial Contributors Tot	$17,224,174	SubstantialContributorsTotAmt
Public Support Total170	$540,150,972	PublicSupportTotal170Amt

Gross Investment Income170 GrossInvestmentIncome170Grp

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	$5,532,193	CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years	$6,303,751	CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years	$5,346,565	CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year	$5,942,288	CurrentTaxYearMinus1YearAmt
Current Tax Year	$3,455,907	CurrentTaxYearAmt
Total	$26,580,704	TotalAmt

Unrelated Business Net Incm170 UnrelatedBusinessNetIncm170Grp

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	$52,137	CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years	$281,883	CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years	$48,551	CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year	$0	CurrentTaxYearMinus1YearAmt
Current Tax Year	$0	CurrentTaxYearAmt
Total	$382,571	TotalAmt

Other Income170 OtherIncome170Grp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt

Field	Value	IRS element (for citing)
Total Support	$584,338,421	TotalSupportAmt
Gross Receipts Rltd Activities	$7,895,918	GrossReceiptsRltdActivitiesAmt
Public Support CY170	0.92438	PublicSupportCY170Pct
Public Support PY170	0.87030	PublicSupportPY170Pct
Thirty Thr Pct Suprt Tests CY170	Yes (X)	ThirtyThrPctSuprtTestsCY170Ind

Schedule B IRS990ScheduleB

Contributor Information ContributorInformationGrp

Field	Value	IRS element (for citing)
Contributor	RESTRICTED	ContributorNum

Contributor Business Name ContributorBusinessName

Field	Value	IRS element (for citing)
Business Name Line1	RESTRICTED	BusinessNameLine1

Contributor US Address ContributorUSAddress

Field	Value	IRS element (for citing)
Address Line1	RESTRICTED	AddressLine1
Address Line2	RESTRICTED	AddressLine2
City	RESTRICTED	City
State	RESTRICTED	State
ZIP Code	RESTRICTED	ZIPCode

Field	Value	IRS element (for citing)
Total Contributions	RESTRICTED	TotalContributionsAmt

Schedule C IRS990ScheduleC

Field	Value	IRS element (for citing)
Total Grassroots Lobbying		TotalGrassrootsLobbyingGrp
Total Direct Lobbying		TotalDirectLobbyingGrp
Total Lobbying Expend		TotalLobbyingExpendGrp
Other Exempt Purpose Expend		OtherExemptPurposeExpendGrp
Total Exempt Purpose Expend		TotalExemptPurposeExpendGrp
Lobbying Nontaxable Amount		LobbyingNontaxableAmountGrp
Grassroots Nontaxable		GrassrootsNontaxableGrp
Tot Lbbyng Grassroot Mns Non Tx		TotLbbyngGrassrootMnsNonTxGrp
Tot Lbby Expend Mns Lbbyng Non Tx		TotLbbyExpendMnsLbbyngNonTxGrp
Volunteers	false	VolunteersInd
Paid Staff Or Management	false	PaidStaffOrManagementInd
Media Advertisements	false	MediaAdvertisementsInd
Media Advertisements	$0	MediaAdvertisementsAmt
Mailings Members	false	MailingsMembersInd
Mailings Members	$0	MailingsMembersAmt
Publications Or Broadcast	false	PublicationsOrBroadcastInd
Publications Or Broadcast	$0	PublicationsOrBroadcastAmt
Grants Other Organizations	false	GrantsOtherOrganizationsInd
Grants Other Organizations	$0	GrantsOtherOrganizationsAmt
Direct Contact Legislators	false	DirectContactLegislatorsInd
Direct Contact Legislators	$0	DirectContactLegislatorsAmt
Rallies Demonstrations	false	RalliesDemonstrationsInd
Rallies Demonstrations	$0	RalliesDemonstrationsAmt
Other Activities	Yes (true)	OtherActivitiesInd
Other Activities	$1,500	OtherActivitiesAmt
Total Lobbying Expenditures	$1,500	TotalLobbyingExpendituresAmt
Not Described Section501c3	false	NotDescribedSection501c3Ind

Supplemental Information Detail SupplementalInformationDetail

Field	Value	IRS element (for citing)
Form And Line Reference	SCHEDULE C, PART II-B, LINE 1I	FormAndLineReferenceDesc
Explanation	DUES TO A RESEARCH AND BIOMEDICAL ORGANIZATION, A PORTION OF WHICH IS CONSIDERED LOBBYING.	ExplanationTxt

Schedule D IRS990ScheduleD

Field	Value	IRS element (for citing)
Art Public Exhibition Amounts		ArtPublicExhibitionAmountsGrp
Held Works Art		HeldWorksArtGrp

CY Endwmt Fund CYEndwmtFundGrp

Field	Value	IRS element (for citing)
Beginning Year Balance	$20,562,387	BeginningYearBalanceAmt
Contributions	$1,005	ContributionsAmt
Investment Earnings Or Losses	$724,999	InvestmentEarningsOrLossesAmt
Other Expenditures	$1,373,539	OtherExpendituresAmt
End Year Balance	$19,914,852	EndYearBalanceAmt

CY Minus1 Yr Endwmt Fund CYMinus1YrEndwmtFundGrp

Field	Value	IRS element (for citing)
Beginning Year Balance	$29,799,743	BeginningYearBalanceAmt
Contributions	$4,000	ContributionsAmt
Investment Earnings Or Losses	$1,337,873	InvestmentEarningsOrLossesAmt
Other Expenditures	$1,327,075	OtherExpendituresAmt
End Year Balance	$29,814,541	EndYearBalanceAmt

CY Minus2 Yr Endwmt Fund CYMinus2YrEndwmtFundGrp

Field	Value	IRS element (for citing)
Beginning Year Balance	$28,681,314	BeginningYearBalanceAmt
Contributions	$502,000	ContributionsAmt
Investment Earnings Or Losses	$1,841,686	InvestmentEarningsOrLossesAmt
Other Expenditures	$1,225,257	OtherExpendituresAmt
End Year Balance	$29,799,743	EndYearBalanceAmt

CY Minus3 Yr Endwmt Fund CYMinus3YrEndwmtFundGrp

Field	Value	IRS element (for citing)
Beginning Year Balance	$25,987,641	BeginningYearBalanceAmt
Contributions	$530,336	ContributionsAmt
Investment Earnings Or Losses	$3,395,420	InvestmentEarningsOrLossesAmt
Other Expenditures	$1,232,083	OtherExpendituresAmt
End Year Balance	$28,681,314	EndYearBalanceAmt

CY Minus4 Yr Endwmt Fund CYMinus4YrEndwmtFundGrp

Field	Value	IRS element (for citing)
Beginning Year Balance	$26,693,919	BeginningYearBalanceAmt
Contributions	$510,067	ContributionsAmt
Investment Earnings Or Losses	-$3,125	InvestmentEarningsOrLossesAmt
Other Expenditures	$1,213,220	OtherExpendituresAmt
End Year Balance	$25,987,641	EndYearBalanceAmt

Field	Value	IRS element (for citing)
Board Designated Balance EOY	0.00000	BoardDesignatedBalanceEOYPct
Prmnnt Endowment Balance EOY	0.70550	PrmnntEndowmentBalanceEOYPct
Term Endowment Balance EOY	0.29450	TermEndowmentBalanceEOYPct
Endowments Held Unrelated Org	false	EndowmentsHeldUnrelatedOrgInd
Endowments Held Related Org	false	EndowmentsHeldRelatedOrgInd

Land LandGrp

Field	Value	IRS element (for citing)
Other Cost Or Other Basis	$12,758,161	OtherCostOrOtherBasisAmt
Book Value	$12,758,161	BookValueAmt

Buildings BuildingsGrp

Field	Value	IRS element (for citing)
Other Cost Or Other Basis	$87,265,126	OtherCostOrOtherBasisAmt
Depreciation	$56,520,257	DepreciationAmt
Book Value	$30,744,869	BookValueAmt

Field	Value	IRS element (for citing)
Leasehold Improvements		LeaseholdImprovementsGrp

Equipment EquipmentGrp

Field	Value	IRS element (for citing)
Other Cost Or Other Basis	$62,276,941	OtherCostOrOtherBasisAmt
Depreciation	$53,031,680	DepreciationAmt
Book Value	$9,245,261	BookValueAmt

Other Land Buildings OtherLandBuildingsGrp

Field	Value	IRS element (for citing)
Other Cost Or Other Basis	$644,267	OtherCostOrOtherBasisAmt
Depreciation	$0	DepreciationAmt
Book Value	$644,267	BookValueAmt

Field	Value	IRS element (for citing)
Total Book Value Land Buildings	$53,392,558	TotalBookValueLandBuildingsAmt
Financial Derivatives		FinancialDerivativesGrp
Closely Held Equity Interests		CloselyHeldEquityInterestsGrp

Other Securities OtherSecuritiesGrp (3 entries)

DescDesc	Book ValueBookValueAmt	Method ValuationMethodValuationCd
PRIVATE EQUITY LPS	$3,378,883	F
TOTAL RETURN HEDGE FUNDS	$8,343,174	F
SELECT EQUITY FUNDS	$16,825,303	F

Field	Value	IRS element (for citing)
Total Book Value Securities	$28,547,360	TotalBookValueSecuritiesAmt
Federal Income Tax Liability	$0	FederalIncomeTaxLiabilityAmt
Total Liability	$0	TotalLiabilityAmt
Footnote Text	Yes (X)	FootnoteTextInd
Total Rev Etc Audited Fincl Stmt	$110,538,000	TotalRevEtcAuditedFinclStmtAmt
Net Unrealized Gains Invst	-$5,565,452	NetUnrealizedGainsInvstAmt
Revenue Not Reported	-$5,565,452	RevenueNotReportedAmt
Revenue Subtotal	$116,103,452	RevenueSubtotalAmt
Investment Expenses Not Incld	$628,171	InvestmentExpensesNotIncldAmt
Other Revenues Not Included	-$1,220	OtherRevenuesNotIncludedAmt
Revenue Not Reported Fincl Stmt	$626,951	RevenueNotReportedFinclStmtAmt
Total Revenue Per Form990	$116,730,403	TotalRevenuePerForm990Amt
Tot Expns Etc Audited Fincl Stmt	$112,020,000	TotExpnsEtcAuditedFinclStmtAmt
Expenses Subtotal	$112,020,000	ExpensesSubtotalAmt
Investment Expenses Not Incld2	$628,171	InvestmentExpensesNotIncld2Amt
Other Expenses Not Included	-$242	OtherExpensesNotIncludedAmt
Expenses Not Rpt Fincl Stmt	$627,929	ExpensesNotRptFinclStmtAmt
Total Expenses Per Form990	$112,647,929	TotalExpensesPerForm990Amt

Supplemental Information Detail SupplementalInformationDetail (4 entries)

Form And Line ReferenceFormAndLineReferenceDesc	ExplanationExplanationTxt
SCHEDULE D, PART V, LINE 4	INTENDED USES OF THE ORGANIZATION'S ENDOWMENT FUNDS THE INSTITUTE'S ENDOWMENT FUNDS ARE ESTABLISHED FOR VARIOUS PURPOSES: SCIENTIFIC RESEARCH, CEO CHAIR, PRESIDENTIAL CHAIR, CANCER AND NEUROSCIENCE LEADERSHIP CHAIRS, AND UNRESTRICTED AS TO INCOME. SCHEDULE D, PART V, LINE 1A FY20 ENDOWMENT BEGINNING BALANCE THE BOARD DESIGNATED ENDOWMENTS OF $9,252,154 WAS REMOVED FROM THE BEGINNING BALANCE ENDOWMENT TOTAL IN ACCORDANCE WITH THE FORM 990 INSTRUCTIONS.
SCHEDULE D, PART X, LINE 2	FIN 48 (ASC 740) FOOTNOTE THE INSTITUTE HAS NO MATERIAL DEFERRED TAX ASSETS OR DEFERRED TAX LIABILITIES RECORDED AS OF JUNE 30, 2020 AND 2019. THE INSTITUTE DID NOT RECOGNIZE A CHANGE IN LIABILITY FOR UNRECOGNIZED TAX BENEFITS (THE DIFFERENCE BETWEEN A TAX POSITION TAKEN, OR EXPECTED TO BE TAKEN, IN A TAX RETURN AND THE BENEFIT RECOGNIZED AND MEASURED IN THE FINANCIAL STATEMENTS). THERE WERE NO LIABILITIES FOR UNRECOGNIZED TAX BENEFITS AT JUNE 30, 2020 AND 2019.
SCHEDULE D, PART XI, LINE 4B	ROUNDING - ($1,220)
SCHEDULE D, PART XII, LINE 4B	ROUNDING - ($242)

Schedule F IRS990ScheduleF

Account Activities Outside US AccountActivitiesOutsideUSGrp (6 entries)

RegionRegionTxt	EmployeeEmployeeCnt	Type Of Activities ConductedTypeOfActivitiesConductedTxt	Specific Services ProvidedSpecificServicesProvidedTxt	Region Total ExpendituresRegionTotalExpendituresAmt
Europe (Including Iceland and Greenland)	24	Program Services	SEE PART V	$79,753
East Asia and the Pacific	1	Program Services	SEE PART V	$9,401
South Asia	3	Program Services	SEE PART V	$7,929
Central America and the Caribbean	4	Program Services	SEE PART V	$3,128
North America	1	Program Services	SEE PART V	$1,741
Central America and the Caribbean	0	Investments		$10,842,516

Field	Value	IRS element (for citing)
Subtotal Offices	0	SubtotalOfficesCnt
Subtotal Employees	33	SubtotalEmployeesCnt
Total Office	0	TotalOfficeCnt
Total Employee	33	TotalEmployeeCnt
Subtotal Spent	$10,944,468	SubtotalSpentAmt
Total Spent	$10,944,468	TotalSpentAmt
Transfer To Foreign Corp	Yes (true)	TransferToForeignCorpInd
Interest In Foreign Trust	false	InterestInForeignTrustInd
Foreign Corp Ownership	Yes (true)	ForeignCorpOwnershipInd
Passive Foreign Investmest Co	Yes (true)	PassiveForeignInvestmestCoInd
Foreign Partnership	Yes (true)	ForeignPartnershipInd
Boycott Countries	false	BoycottCountriesInd

Supplemental Information Detail SupplementalInformationDetail (3 entries)

Form And Line ReferenceFormAndLineReferenceDesc	ExplanationExplanationTxt
SCHEDULE F, PART I, LINE 3	PROGRAM SERVICE ACTIVITIES SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE DOES NOT MAINTAIN ONGOING OPERATIONS IN FOREIGN JURISDICTIONS. HOWEVER, THE INSTITUTE'S SCIENTIST DO TRAVEL TO VARIOUS SCIENTIFIC CONFERENCES IN OTHER COUNTRIES TO SHARE THE INSTITUTE'S SCIENTIFIC DISCOVERIES, AS WELL AS, TO LEARN FROM OTHER SCIENTISTS ACROSS THE WORLD.
SCHEDULE F, PART I, LINE 3, COLUMN E	TYPE OF SERVICE SPECIFIC PROGRAM SERVICE ACTIVITY IN ALL REGIONS IS AGENTS ATTENDING AND/OR SPEAKING AT SCIENTIFIC CONFERENCES AND COLLABORATIONS.
SCHEDULE F, PART I, LINE 3, COLUMN F	ACCOUNTING METHOD THE ACCRUAL METHOD OF ACCOUNTING WAS USED TO DETERMINE THE AMOUNTS IN PART I, LINE 3, COLUMN F.

Schedule G IRS990ScheduleG

Fundraiser Activity Info FundraiserActivityInfoGrp (2 entries)

ActivityActivityTxt	Fundraiser Control Of FundsFundraiserControlOfFundsInd
ED GILLENWATERS
CONSULTING	false
BLAIR BLUM PARTNERS
CONSULTING	false

Fundraising Event Information FundraisingEventInformationGrp

Field	Value	IRS element (for citing)
Event1	GALA	Event1Nm
Gross Receipts Event1	$334,815	GrossReceiptsEvent1Amt
Charitable Contri Event1	$307,815	CharitableContriEvent1Amt
Gross Revenue Event1	$27,000	GrossRevenueEvent1Amt
Food And Beverage Event1	$54,589	FoodAndBeverageEvent1Amt
Entertainment Event1	$37,987	EntertainmentEvent1Amt
Other Direct Expenses Event1	$67,324	OtherDirectExpensesEvent1Amt
Other Events Total	0	OtherEventsTotalCnt
Gross Receipts Total	$334,815	GrossReceiptsTotalAmt
Charitable Contributions Tot	$307,815	CharitableContributionsTotAmt
Gross Revenue Total Events	$27,000	GrossRevenueTotalEventsAmt
Food And Beverage Total Events	$54,589	FoodAndBeverageTotalEventsAmt
Entertainment Total Events	$37,987	EntertainmentTotalEventsAmt
Oth Direct Expnss Total Events	$67,324	OthDirectExpnssTotalEventsAmt
Direct Expense Summary Events	$159,900	DirectExpenseSummaryEventsAmt
Net Income Summary	-$132,900	NetIncomeSummaryAmt

Schedule J IRS990ScheduleJ

Field	Value	IRS element (for citing)
First Class Or Charter Travel	Yes (X)	FirstClassOrCharterTravelInd
Club Dues Or Fees	Yes (X)	ClubDuesOrFeesInd
Written Policy Ref T And E Expnss	Yes (true)	WrittenPolicyRefTAndEExpnssInd
Substantiation Required	Yes (true)	SubstantiationRequiredInd
Compensation Committee	Yes (X)	CompensationCommitteeInd
Independent Consultant	Yes (X)	IndependentConsultantInd
Form990 Of Other Organizations	Yes (X)	Form990OfOtherOrganizationsInd
Written Employment Contract	Yes (X)	WrittenEmploymentContractInd
Compensation Survey	Yes (X)	CompensationSurveyInd
Board Or Committee Approval	Yes (X)	BoardOrCommitteeApprovalInd
Severance Payment	false	SeverancePaymentInd
Supplemental Nonqual Rtr Plan	Yes (true)	SupplementalNonqualRtrPlanInd
Equity Based Comp Arrngm	false	EquityBasedCompArrngmInd
Comp Based On Revenue Of Flng Org	false	CompBasedOnRevenueOfFlngOrgInd
Comp Bsd On Rev Related Orgs	false	CompBsdOnRevRelatedOrgsInd
Comp Bsd Net Earns Flng Org	false	CompBsdNetEarnsFlngOrgInd
Comp Bsd Net Earns Rltd Orgs	false	CompBsdNetEarnsRltdOrgsInd
Any Non Fixed Payments	Yes (true)	AnyNonFixedPaymentsInd
Initial Contract Exception	false	InitialContractExceptionInd

Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp (7 entries)

TitleTitleTxt	Base Compensation Filing OrgBaseCompensationFilingOrgAmt	Compensation Based On Rltd OrgsCompensationBasedOnRltdOrgsAmt	Bonus Filing OrganizationBonusFilingOrganizationAmount	Bonus Related OrganizationsBonusRelatedOrganizationsAmt	Other Compensation Filing OrgOtherCompensationFilingOrgAmt	Other Compensation Rltd OrgsOtherCompensationRltdOrgsAmt	Deferred Compensation Flng OrgDeferredCompensationFlngOrgAmt	Deferred Comp Rltd OrgsDeferredCompRltdOrgsAmt	Nontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgAmt	Nontaxable Benefits Rltd OrgsNontaxableBenefitsRltdOrgsAmt	Total Compensation Filing OrgTotalCompensationFilingOrgAmt	Total Compensation Rltd OrgsTotalCompensationRltdOrgsAmt	Comp Report Prior990 Filing OrgCompReportPrior990FilingOrgAmt	Comp Report Prior990 Rltd OrgsCompReportPrior990RltdOrgsAmt
KRISTIINA VUORI MD PHD
PRESIDENT	$770,603	$0	$250,000	$0	$2,014	$0	$328,000	$0	$22,424	$0	$1,373,041	$0	$0	$0
GARTH POWIS PHD
CENTER DIRECTOR	$448,552	$0	$50,000	$0	$5,980	$0	$28,000	$0	$25,042	$0	$557,574	$0	$0	$0
CARL WARE PHD
CENTER DIRECTOR, IIDC	$394,063	$0	$38,940	$0	$4,963	$0	$28,000	$0	$24,965	$0	$490,931	$0	$0	$0
LOUIS COFFMAN
CAO & CFO	$379,609	$0	$50,000	$0	$5,114	$0	$14,063	$0	$26,593	$0	$475,379	$0	$0	$0
MICHAEL JACKSON PHD
DRUG DISCOVERY & DEV, SR VP	$408,973	$0	$20,289	$0	$3,094	$0	$28,000	$0	$30,766	$0	$491,122	$0	$0	$0
ZE'EV RONAI PHD
PROGRAM DIRECTOR	$344,715	$0	$34,204	$0	$4,358	$0	$28,000	$0	$37,401	$0	$448,678	$0	$0	$0
JORGE MOSCAT PHD
PROGRAM DIRECTOR	$409,194	$0	$17,528	$0	$4,336	$0	$28,000	$0	$27,855	$0	$486,913	$0	$0	$0

Supplemental Information Detail SupplementalInformationDetail (3 entries)

Form And Line ReferenceFormAndLineReferenceDesc	ExplanationExplanationTxt
FORM 990, SCHEDULE J, PART I, LINE 1A	FIRST CLASS TRAVEL FIRST CLASS TRAVEL IS GENERALLY NOT PERMITTED, EXCEPT UNDER VERY LIMITED AND RARE CIRCUMSTANCES AND CONDITIONS, SUCH AS A MEDICAL CONDITION REQUIREMENT AND URGENT CIRCUMSTANCES. THIS WAS NOT TREATED AS TAXABLE COMPENSATION. HEALTH OR SOCIAL CLUB DUES HEALTH OR SOCIAL CLUB DUES ARE NEGOTIATED IN THE HIRING PROCESS FOR CERTAIN EMPLOYEES. THE AMOUNTS WERE TREATED AS TAXABLE COMPENSATION.
FORM 990, SCHEDULE J, PART I, LINE 4B	SUPPLEMENTAL NONQUALIFIED RETIREMENT PLAN THE PARTICIPANT OF THE 457(F) DEFERRED COMPENSATION PLAN IS KRISTIINA VUORI. VESTING OCCURS THE EARLIEST OF 04/01/20, OR INVOLUNTARY TERMINATION WITHOUT CAUSE, OR PARTICIPANT'S RESIGNATION FOR GOOD CAUSE, OR THE DATE OF TERMINATION OF THE PLAN. DISTRIBUTION IS A ONE-TIME LUMP SUM PAYMENT UPON VESTING OF 100% OF THE VALUE OF THE PARTICIPANT'S INVESTMENT (COMPRISED OF INSTITUTE CONTRIBUTIONS TO THE CORPUS PLUS ANY INVESTMENT GAINS OR LOSSES THEREON). THE AMOUNTS VESTED WERE INCLUDED IN CALENDAR YEAR 2020 COMPENSATION WILL BE REPORTED ACCORDINGLY ON THE 2020 FORM 990.
FORM 990, SCHEDULE J, PART I, LINE 7	NON FIXED PAYMENTS SOME SENIOR EXECUTIVES HAVE EMPLOYMENT AGREEMENTS STIPULATING A BONUS WILL BE PAID TO THEM PROVIDED CERTAIN GOALS OR ACCOMPLISHMENTS ARE ACHIEVED.

Schedule K IRS990ScheduleK

Tax Exempt Bonds Issues TaxExemptBondsIssuesGrp

Field	Value	IRS element (for citing)
Bond Reference	A	BondReferenceCd

Issuer Name IssuerName

Field	Value	IRS element (for citing)
Business Name Line1	COUNTY OF SAN DIEGO	BusinessNameLine1Txt

Field	Value	IRS element (for citing)
Bond Issuer EIN	956000934	BondIssuerEIN
CUSIP	79742YAQ5	CUSIPNum
Bond Issued	2015-11-12	BondIssuedDt
Issue Price	$61,963,256	IssuePriceAmt
Purpose	SEE PART VI	PurposeDesc
Defeased	false	DefeasedInd
On Behalf Of Issuer	false	OnBehalfOfIssuerInd
Pool Financing	false	PoolFinancingInd

Tax Exempt Bonds Proceeds TaxExemptBondsProceedsGrp

Field	Value	IRS element (for citing)
Bond Reference	A	BondReferenceCd
Retired	$0	RetiredAmt
Bond Defeased	$15,643,870	BondDefeasedAmt
Total Proceeds	$61,963,256	TotalProceedsAmt
In Reserve Fund	$0	InReserveFundAmt
Capitalized Interest	$0	CapitalizedInterestAmt
Refunding Escrow	$46,030,000	RefundingEscrowAmt
Issuance Costs From Proceeds	$289,386	IssuanceCostsFromProceedsAmt
Credit Enhancement	$0	CreditEnhancementAmt
Working Capital Expenditures	$0	WorkingCapitalExpendituresAmt
Capital Expenditures	$0	CapitalExpendituresAmt
Other Spent Proceeds	$0	OtherSpentProceedsAmt
Unspent	$0	UnspentAmt
Substantial Completion	2015	SubstantialCompletionYr
Refunding Tax Exempt Bonds	Yes (true)	RefundingTaxExemptBondsInd
Refunding Taxable Bonds	false	RefundingTaxableBondsInd
Final Allocation Made	Yes (true)	FinalAllocationMadeInd
Adequate Books And Rec Maint	Yes (true)	AdequateBooksAndRecMaintInd

Tax Exempt Bonds Private Bus Use TaxExemptBondsPrivateBusUseGrp

Field	Value	IRS element (for citing)
Bond Reference	A	BondReferenceCd
Owning Bond Financed Property	false	OwningBondFinancedPropertyInd
Any Lease Arrangements	Yes (true)	AnyLeaseArrangementsInd
Mgmt Contract Bond Fincd Prop	Yes (true)	MgmtContractBondFincdPropInd
Engage Bond Counsel Contracts	Yes (true)	EngageBondCounselContractsInd
Any Research Agreements	Yes (true)	AnyResearchAgreementsInd
Engage Bond Counsel Research	Yes (true)	EngageBondCounselResearchInd
Private Bus Use By Others	0.01450	PrivateBusUseByOthersPct
Total Private Business Use	0.01450	TotalPrivateBusinessUsePct
Bond Iss Meet Prvt Sec Pymt Test	false	BondIssMeetPrvtSecPymtTestInd
Change In Use Bond Financed Prop	false	ChangeInUseBondFinancedPropInd
Remedial Action Taken	false	RemedialActionTakenInd
Procs Nonqualified Bond Remdtd	Yes (true)	ProcsNonqualifiedBondRemdtdInd

Tax Exempt Bonds Arbitrage TaxExemptBondsArbitrageGrp

Field	Value	IRS element (for citing)
Bond Reference	A	BondReferenceCd
Form8038 T Filed	false	Form8038TFiledInd
Rebate Not Due Yet	Yes (true)	RebateNotDueYetInd
Exception To Rebate	false	ExceptionToRebateInd
No Rebate Due	false	NoRebateDueInd
Variable Rate Issue	Yes (true)	VariableRateIssueInd
Hedge Identified In Bks And Rec	false	HedgeIdentifiedInBksAndRecInd

Hedge Provider Name HedgeProviderName

Field	Value	IRS element (for citing)
Business Name Line1	0	BusinessNameLine1Txt

Field	Value	IRS element (for citing)
Gross Proceeds Invested In GIC	false	GrossProceedsInvestedInGICInd

GIC Provider Name GICProviderName

Field	Value	IRS element (for citing)
Business Name Line1	0	BusinessNameLine1Txt

Field	Value	IRS element (for citing)
Gross Proceeds Invested	false	GrossProceedsInvestedInd
Written Proc To Monitor Reqs	Yes (true)	WrittenProcToMonitorReqsInd

Procedures Corrective Action ProceduresCorrectiveActionGrp

Field	Value	IRS element (for citing)
Bond Reference	A	BondReferenceCd
Procedures Corrective Action	Yes (true)	ProceduresCorrectiveActionInd

Supplemental Information Detail SupplementalInformationDetail (2 entries)

Form And Line ReferenceFormAndLineReferenceDesc	ExplanationExplanationTxt
SCHEDULE K, PART I, ROW A, COLUMN (F)	REFINANCE 2006 AND 2012 BONDS WITH ISSUE DATES OF 02/01/2006 AND 11/15/2012, RESPECTIVELY.
SCHEDULE K, PART I, ROW A	FOR THE BOND ISSUES LISTED IN PART I, THE ALTERNATIVE PERIOD USED FOR THE REPORTING REQUIREMENTS IN THIS SECTION IS THE TWELVE MONTHS ENDED DECEMBER 31, 2019.

Schedule M IRS990ScheduleM

Field	Value	IRS element (for citing)
Works Of Art		WorksOfArtGrp
Art Historical Treasures		ArtHistoricalTreasuresGrp
Art Fractional Interest		ArtFractionalInterestGrp
Books And Publications		BooksAndPublicationsGrp
Clothing And Household Goods		ClothingAndHouseholdGoodsGrp
Cars And Other Vehicles		CarsAndOtherVehiclesGrp
Boats And Planes		BoatsAndPlanesGrp
Intellectual Property		IntellectualPropertyGrp
Securities Publicly Traded		SecuritiesPubliclyTradedGrp
Securities Closely Held Stock		SecuritiesCloselyHeldStockGrp
Secur Prtnrshp Trust Intrsts		SecurPrtnrshpTrustIntrstsGrp
Securities Miscellaneous		SecuritiesMiscellaneousGrp
Qualified Contrib Hist Struct		QualifiedContribHistStructGrp
Qualified Contrib Other		QualifiedContribOtherGrp
Real Estate Residential		RealEstateResidentialGrp
Real Estate Commercial		RealEstateCommercialGrp
Real Estate Other		RealEstateOtherGrp
Collectibles		CollectiblesGrp
Food Inventory		FoodInventoryGrp
Drugs And Medical Supplies		DrugsAndMedicalSuppliesGrp
Taxidermy		TaxidermyGrp
Historical Artifacts		HistoricalArtifactsGrp
Scientific Specimens		ScientificSpecimensGrp
Archaeological Artifacts		ArchaeologicalArtifactsGrp

Other Non Cash Contri Table OtherNonCashContriTableGrp (2 entries)

Non Cash CheckboxNonCashCheckboxInd	DescDesc	ContributionContributionCnt	Noncash Contributions Rpt F990NoncashContributionsRptF990Amt	Method Of Determining RevenuesMethodOfDeterminingRevenuesTxt
Yes (X)	hand sanitizer, gal.	36	$2,580	FMV
Yes (X)	surgical masks	57400	$53,000	FMV

Field	Value	IRS element (for citing)
Any Property That Must Be Held	false	AnyPropertyThatMustBeHeldInd
Review Process Unusual NC Gifts	false	ReviewProcessUnusualNCGiftsInd
Third Parties Used	false	ThirdPartiesUsedInd

Supplemental Information Detail SupplementalInformationDetail

Field	Value	IRS element (for citing)
Form And Line Reference	FORM 990, SCHEDULE M, PART I, LINE 25, COLUMN (B)	FormAndLineReferenceDesc
Explanation	COLUMN B IS REPORTING A COMBINATION OF THE NUMBER OF CONTRIBUTIONS RECEIVED AND THE NUMBER OF ITEMS RECEIVED.	ExplanationTxt

Schedule O IRS990ScheduleO

Supplemental Information Detail SupplementalInformationDetail (7 entries)

Form And Line ReferenceFormAndLineReferenceDesc	ExplanationExplanationTxt
FORM 990 , PART I, LINE 1 & PART III, LINE 1	ORGANIZATIONS MISSION SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE CONDUCTS WORLD-CLASS, COLLABORATIVE RESEARCH DEDICATED TO FINDING CURES FOR HUMAN DISEASE, IMPROVING THE QUALITY OF LIFE, AND THUS CREATING A LEGACY FOR ITS EMPLOYEES, PARTNERS, DONORS, AND COMMUNITY.
FORM 990, PART III, LINE 4	SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE (SBP) IS AN INDEPENDENT NONPROFIT MEDICAL RESEARCH ORGANIZATION THAT DEDICATED TO UNCOVERING THE ORIGINS OF DISEASE AND LAUNCHING BOLD NEW STRATEGIES LAYING THE FOUNDATION FOR CURES. OUR INSTITUTE HAS DEEP EXPERTISE IN FUNDAMENTAL BIOLOGY AND ONE OF THE MOST COMPREHENSIVE DRUG DISCOVERY CENTERS IN THE NONPROFIT WORLD. CANCER MICROFLUID DEVICE CAPTURES CIRCULATING TUMOR CELL CLUSTERS: NEARLY 90% OF CANCER DEATHS ARE DUE TO METASTASES, WHEN TUMORS SPREAD THROUGHOUT THE BODY. TO HELP SCIENTISTS STUDY THIS PROCESS, RESEARCHERS FROM SANFORD BURNHAM PREBYS, SAN DIEGO STATE UNIVERSITY AND TUMORGEN MDX INC. CREATED A MICROFLUIDIC DEVICE THAT CAPTURES CIRCULATING CANCER CELL CLUSTERS. THE TECHNOLOGY WAS DESCRIBED IN AIP ADVANCES. DIGESTION-AIDING HERBS ALTER GUT MICROBIOME: A STUDY PUBLISHED BY SANFORD BURNHAM PREBYS AND UC SAN DIEGO SCIENTISTS IN EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE FOUND THAT DIGESTION-AIDING HERBS PROMOTED STRONG SHIFTS IN GUT BACTERIA KNOWN TO REGULATE METABOLISM. THIS INSIGHT MAY LEAD TO TREATMENTS FOR COLON CANCER, AUTOIMMUNE CONDITIONS AND MORE SERIOUS DISEASES. PREBIOTICS HELP FIGHT MELANOMA BY ACTIVATING ANTI-TUMOR IMMUNITY: TWO PREBIOTICS-NUTRIENTS THAT FEED THE FRIENDLY BACTERIA IN THE GUT-SLOWED THE GROWTH OF MELANOMA IN MICE BY BOOSTING THE IMMUNE SYSTEMS ABILITY TO FIGHT CANCER. THE STUDY, LED BY ZEEV RONAI, PH.D., PROVIDES FURTHER EVIDENCE THAT GUT MICROBES PLAY A ROLE IN SHAPING THE IMMUNE RESPONSE TO CANCER, AND SUPPORTS EFFORTS TO TARGET THE GUT MICROBIOME TO ENHANCE THE EFFICACY OF CANCER THERAPY. (CELL REPORTS) PANCREATIC CANCER BLOCKED BY DISRUPTING CELLULAR PH BALANCE: A NEW STUDY BY COSIMO COMMISSO, PH.D., ILLUSTRATES THE POTENTIAL TO TARGET CELLULAR PH-A MEASURE OF ACIDITY-AS AN APPROACH TO COMBATING PANCREATIC CANCER. BY SUPPRESSING SPECIFIC PROTEINS, THE RESEARCH TEAM WAS ABLE TO DISRUPT THE ACIDIC PH THAT CANCER CELLS USE TO SUPPORT THEIR METABOLISM. THE TEAMS NEXT STEP IS TO WORK WITH OUR DRUG DISCOVERY TEAM IN THE PREBYS CENTER TO FIND DRUGS THAT SEQUESTER ACID AND COMPROMISE PANCREATIC CELL GROWTH. (CANCER DISCOVERY) ONE-TWO PUNCH DRUG COMBINATION OFFERS HOPE FOR PANCREATIC CANCER: PANCREATIC CANCER IS ONE OF THE DEADLIEST FORMS OF CANCER-FEWER THAN 10 PERCENT OF PEOPLE REMAIN ALIVE FIVE YEARS AFTER DIAGNOSIS. ZE'EV RONAI, PH.D., IDENTIFIED A COMBINATION OF TWO FDA-APPROVED DRUGS THAT SHRANK PANCREATIC TUMORS IN MICE. THE DRUGS ARE CURRENTLY USED TO TREAT CERTAIN LEUKEMIAS AND SOLID TUMORS. THE RESEARCH SUPPORTS THE IMMEDIATE EVALUATION OF THE DRUG COMBINATION IN CLINICAL TRIALS FOR PANCREATIC CANCER. (NATURE CELL BIOLOGY) NEW SURVIVAL STRATEGY FOR OXYGEN-STARVED PANCREATIC CANCER CELLS: BY BLOCKING PANCREATIC CANCERS OXYGEN-SENSING MACHINERY-THE SAME FIELD OF RESEARCH STUDIED BY THE WINNERS OF THE 2019 NOBEL PRIZE IN MEDICINE-OUR SCIENTISTS HAVE UNCOVERED A PREVIOUSLY UNKNOWN TECHNIQUE TUMORS USE TO SPROUT BLOOD VESSELS, CALLED ANGIOGENESIS. THE DISCOVERY, PUBLISHED IN CANCER RESEARCH, COULD LEAD TO A TREATMENT THAT IS GIVEN WITH AN ANTI-ANGIOGENETIC MEDICINE AND OVERCOMES DRUG RESISTANCE. BOOSTING THE IMMUNE SYSTEM'S ABILITY TO FIGHT CANCER: CANCER IMMUNOTHERAPIES HAVE REVOLUTIONIZED THE TREATMENT OF CERTAIN CANCERS, BUT THEY DON'T WORK FOR EVERYONE. ZE'EV RONAI, PH.D., HAS SHOWN THAT THE SIAH2 PROTEIN HELPS CONTROL IMMUNE CELLS CALLED T REGULATORY CELLS, WHICH LIMIT THE EFFECTIVENESS OF IMMUNOTHERAPIES. THE RESEARCH, WHICH OFFERS A NEW WAY TO PURSUE IMMUNOTHERAPY IN CASES WHERE THE TREATMENT FAILS, WAS PUBLISHED IN NATURE COMMUNICATIONS. IMMUNOTHERAPY COMBINATION ERADICATES PEDIATRIC BRAIN CANCER: WHEN IMMUNOTHERAPY WORKS, IT CAN BE LIFE-CHANGING. BUT IT DOESN'T WORK FOR EVERYONE OR EVERY CANCER. NOW ROBERT WECHSLER-REYA, PH.D., HAS SHOWN THAT COMBINING IMMUNOTHERAPY WITH A DRUG CALLED TUMOR NECROSIS FACTOR ERADICATES A DEADLY PEDIATRIC BRAIN TUMOR IN MICE. THE DISCOVERY, PUBLISHED IN NATURE NEUROSCIENCE, IS EXPECTED TO LEAD TO A CLINICAL TRIAL FOR CHILDREN FIGHTING BRAIN CANCER. PREVENTING PANCREATIC CANCER METASTASIS BY KEEPING CELLS "SHELTERED IN PLACE": COSIMO COMMISSO, PH.D., HAS SHOWN THAT PANCREATIC CANCER METASTASIS-WHEN TUMOR CELLS GAIN THE ABILITY TO MIGRATE TO NEW PARTS OF THE BODY-CAN BE SUPPRESSED BY INHIBITING A PROTEIN THAT REGULATES CELL MOVEMENT, CALLED SLUG. THE STUDY, PUBLISHED IN THE JOURNAL OF EXPERIMENTAL MEDICINE, ALSO REVEALED TWO DRUGGABLE TARGETS THAT COULD LEAD TO TREATMENTS THAT STOP THE SPREAD OF PANCREATIC CANCER. DEGENERATIVE DISEASES ANTIMICROBIAL PROTEIN IMPLICATED IN PARKINSON'S DISEASE: AN IMMUNE SYSTEM PROTEIN THAT TYPICALLY PROTECTS THE BODY FROM PATHOGENS IS ABNORMALLY PRODUCED IN THE BRAIN DURING PARKINSON'S DISEASE, SCIENTISTS FROM SANFORD BURNHAM PREBYS REPORT. THE DISCOVERY, PUBLISHED IN FREE RADICAL BIOLOGY & MEDICINE, INDICATES THAT DEVELOPING A DRUG THAT BLOCKS THIS PROTEIN, CALLED MYELOPEROXIDASE, MAY HELP PEOPLE WITH PARKINSON'S DISEASE. PROTECTING PREMATURE BABIES FROM A COMMON BRAIN DISORDER: PREMATURE BABIES HAVE DELICATE BRAIN TISSUE THAT IS PRONE TO BLEEDING AND POST-HEMORRHAGIC HYDROCEPHALUS, A DANGEROUS CONDITION THAT LEADS TO EXCESS FLUID AND BRAIN DYSFUNCTION. JEROLD CHUN M.D., PH.D., LED A STUDY THAT OPENS NEW AVENUES TO PURSUE COMMERCIALLY AVAILABLE COMPOUNDS THAT PREVENT EXCESS FLUID FROM ACCUMULATING IN THE BRAINS OF PREMATURE INFANTS. (SCIENCE ADVANCES)
DEVELOPMENT, AGING AND REGENERATION	AN EARLY SIGN OF TYPE 2 DIABETES: MISFOLDED PROINSULIN: MISFOLDED PROINSULIN-A PROTEIN THE BODY NORMALLY PROCESSES INTO INSULIN-IS AN EARLY SIGN OF TYPE 2 DIABETES, ACCORDING TO A STUDY BY RANDAL KAUFMAN, PH.D. THE DISCOVERY COULD LEAD TO TESTS OR TREATMENTS THAT HELP PREVENT MORE THAN 80 MILLION AMERICANS WITH PREDIABETES FROM DEVELOPING FULL-BLOWN TYPE 2 DIABETES. THE STUDY WAS PUBLISHED IN ELIFE. MACHINE LEARNINGS NEXT FRONTIER: EPIGENETIC DRUG DISCOVERY: MACHINE LEARNINGS POWERFUL ABILITY TO DETECT PATTERNS IN COMPLEX DATA IS REVOLUTIONIZING HOW WE DRIVE CARS, DIAGNOSE DISEASE, AND NOW HOW WE DISCOVER NEW DRUGS. ALEXEY TERSKIKH, PH.D., HAS DEVELOPED A MACHINE LEARNING ALGORITHM THAT GLEANS INFORMATION FROM MICROSCOPIC DNA IMAGES-ALLOWING FOR A NEW TYPE OF HIGH-THROUGHPUT DRUG SCREENS THAT PROVIDE INSIGHTS INTO CANCER, HEART DISEASE, MENTAL ILLNESS AND OTHER HEALTH CONDITIONS. (ELIFE) A DEEP DIVE INTO CELL AGING: AN FDA-APPROVED DRUG THAT HELPED SUPPRESS THE DAMAGING EFFECTS OF CELL AGING WAS DESCRIBED IN A NEW STUDY BY PETER ADAMS, PH.D. THE RESEARCH, PERFORMED IN MICE, EXAMINED HOW AGING CELLS ENTER A SLEEP-LIKE STATE OF AGING CALLED SENESCENCE. THE STUDY IDENTIFIED A DRUG, CURRENTLY USED TO TREAT CERTAIN CANCERS, THAT TRANSFORMED SENESCENT CELLS FROM A LARGE AND FLAT FORM TO A VISUALLY YOUTHFUL CONDITION. THE TEAM PLANS TO WORK WITH THE PREBYS CENTER TO SCREEN FOR LESS TOXIC VERSIONS OF THE DRUG. (GENES & DEVELOPMENT) LONG-SOUGHT PROTEIN STRUCTURE OFFERS NEW APPROACH TO TREATING DISEASE: FRANCESCA MARASSI, PH.D., LED A COLLABORATION THAT SOLVED THE STRUCTURE OF AN ESSENTIAL BLOOD PROTEIN: VITRONECTIN. KNOWING THE PROTEIN'S STRUCTURE MAY ADVANCE OUR UNDERSTANDING OF A BROAD RANGE OF CONDITIONS INCLUDING MULTI-DRUG-RESISTANT INFECTIONS, CANCER METASTASIS, AGE-RELATED MACULAR DEGENERATION AND MORE. (SCIENCE ADVANCES) MRI PREDICTS EFFICACY OF STEM CELL THERAPY FOR BRAIN INJURY: TOOLS THAT PREDICT THE EFFICACY OF NEURAL STEM CELL THERAPY COULD INCREASE THE SUCCESS OF CLINICAL TRIALS, WHICH ARE ONGOING IN PEOPLE WITH PARKINSON'S DISEASE, SPINAL CORD INJURY AND OTHER NEUROLOGICAL CONDITIONS. EVAN SNYDER, M.D., PH.D., SUCCESSFULLY USED MRI TECHNOLOGY TO PREDICT OUTCOMES IN ANIMAL MODELS OF NEURAL INJURY. HE IS NOW PLANNING A CLINICAL TRIAL FOR BABIES BORN WITH A SPECIFIC TYPE OF BIRTH-RELATED BRAIN INJURY. (CELL REPORTS) THE SECRET TO A LONG LIFE? FOR WORMS, A CELLULAR RECYCLING PROTEIN IS KEY: NEW RESEARCH, LED BY MALENE HANSEN, PH.D., DISCOVERED THAT EXCESS LEVELS OF A SPECIFIC PROTEIN HELPS WORMS LIVE LONGER. THE PROTEIN RECOGNIZES AND DESTROYS TOXIC PROTEINS TO KEEP CELLS HEALTHY. THE FINDINGS OPEN NEW RESEARCH OPPORTUNITIES FOR AGE-RELATED CONDITIONS SUCH AS ALZHEIMER'S DISEASE, WHICH ARE OFTEN CAUSED BY THE ACCUMULATION OF MISFOLDED, HARMFUL PROTEINS. (NATURE COMMUNICATIONS) DNA SHAPE MAKES A BIG DIFFERENCE IN YOUR HEALTH: PIER LORENZO PURI, M.D., HAS USED A CUTTING-EDGE GENOMIC TECHNOLOGY TO SHOW THAT MYOD-A MASTER REGULATOR OF MUSCLE DEVELOPMENT-CAN ALTER THE GENOME'S ARCHITECTURE AND DETERMINE IF DNA MUTATIONS ARE EXPRESSED OR HIDDEN. THE STUDY, PUBLISHED IN MOLECULAR CELL, HELPS EXPLAIN WHY PATIENTS WITH THE SAME MUTATION CAN HAVE DIFFERENT DISEASE PROGRESSION AND SYMPTOMS. RESEARCH UNCOVERS GENETIC MUTATIONS LINKED TO AUTISM SPECTRUM DISORDER: SCIENTISTS AT SANFORD BURNHAM PREBYS AND RADBOUD UNIVERSITY MEDICAL CENTER IN THE NETHERLANDS HAVE IDENTIFIED MUTATIONS IN A GENE CALLED CNOT1 THAT AFFECT BRAIN DEVELOPMENT AND IMPAIR MEMORY AND LEARNING. THE RESEARCH, PUBLISHED IN THE AMERICAN JOURNAL OF HUMAN GENETICS, ALSO REVEALED THAT CNOT1 INTERACTS WITH SEVERAL KNOWN AUTISM SPECTRUM DISORDER GENES, OPENING NEW RESEARCH AVENUES FOR THE CONDITION. POTENTIAL DRUG TARGET FOR TYPE 2 DIABETES REVEALED BY MAPPING PROINSULINS "SOCIAL NETWORK": FOR THE FIRST TIME, SANFORD BURNHAM PREBYS SCIENTISTS HAVE MAPPED THE VAST NETWORK OF PROTEINS THAT INTERACT WITH PROINSULIN, THE PROTEIN THE BODY NORMALLY PROCESSES INTO INSULIN. THE STUDY, PUBLISHED IN DIABETES, REVEALED ONE PROTEIN-CALLED PRDX4-THAT MAY BE ESSENTIAL FOR PROINSULIN FOLDING AND INSULIN PRODUCTION. THE RESEARCH SUGGESTS THAT BOOSTING PRDX4 LEVELS MAY IMPROVE THE HEALTH OF PEOPLE WITH DIABETES. HUMAN GENETICS ADVANCING STEM CELL THERAPIES FOR BRAIN INJURY: EVAN SNYDER, M.D., PH.D., TEAMED UP WITH SCIENTISTS AT LOMA LINDA UNIVERSITY HEALTH TO DEMONSTRATE THE PROMISE OF USING MAGNETIC RESONANCE IMAGING (MRI) TO HELP PREDICT THE EFFICACY OF STEM CELL TREATMENTS FOR NEUROLOGICAL DISORDERS. THE RESEARCHERS ARE PLANNING A CLINICAL TRIAL FOR NEWBORNS WHO EXPERIENCE A BIRTH-RELATED BRAIN INJURY. THE STUDY WAS PUBLISHED IN CELL REPORTS. FIRST SUPERCENTENARIAN IPSCS CREATED: EVAN SNYDER, M.D., PH.D., HAS SUCCESSFULLY REPROGRAMMED CELLS FROM A 114-YEAR-OLD WOMAN INTO INDUCED PLURIPOTENT STEM CELLS (IPSCS). NOW, STUDIES CAN BEGIN TO REVEAL THE "SECRET SAUCE" OF SUPERCENTENARIANS-WHO LIVE REMARKABLY LONG AND HEALTHY LIVES. THE STUDY WAS PUBLISHED IN BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. NEW TEST FOR RARE DISEASE IDENTIFIES CHILDREN WHO MAY BENEFIT FROM SIMPLE SUPPLEMENT: HUDSON FREEZE, PH.D., TEAMED WITH SCIENTISTS AT THE CENTRO DE BIOLOGA MOLECULAR SEVERO OCHOA IN SPAIN TO CREATE A TEST THAT DETERMINES WHICH CHILDREN WITH CAD DEFICIENCY-A RARE METABOLIC DISEASE-ARE LIKELY TO BENEFIT FROM RECEIVING URIDINE, A NUTRITIONAL SUPPLEMENT THAT CAN DRAMATICALLY IMPROVE THE LIVES OF CHILDREN WITH THE CONDITION. THE STUDY WAS PUBLISHED IN GENETICS IN MEDICINE. IMMUNITY AND PATHOGENESIS FOUR DRUGS HOLD NEAR-TERM PROMISE TO FIGHT COVID-19: SUMIT CHANDA, PH.D., LED AN INTERNATIONAL COLLABORATION THAT SCREENED MORE THAN 12,000 EXISTING DRUGS FOR ACTIVITY AGAINST SARS-COV-2, THE VIRUS THAT CAUSES COVID-19. FOUR OF THE DRUGS WERE ABLE TO STOP THE VIRUS FROM REPLICATING AT DOSES LIKELY TO BE EFFECTIVE AND TOLERABLE IN HUMANS. THE RESEARCH INCREASES THE NUMBER OF "SHOTS ON GOAL" FOR A POTENTIAL TREATMENT AND COULD REACH PATIENTS FASTER THAN DRUGS CREATED FROM SCRATCH. (BIORXIV) NEW DRUG CANDIDATE REAWAKENS SLEEPING HIV IN HOPES OF A CURE: SANFORD BURNHAM PREBYS SCIENTISTS HAVE DESIGNED A NEXT-GENERATION DRUG CALLED CIAPAVIR THAT IS EFFECTIVE AT REACTIVATING DORMANT HUMAN IMMUNODEFICIENCY VIRUS (HIV). THE RESEARCH, PUBLISHED IN CELL REPORTS MEDICINE, AIMS TO CREATE A FUNCTIONAL HIV CURE USING A "SHOCK AND KILL" APPROACH THAT FIRST ACTIVATES AND THEN ELIMINATES ALL POCKETS OF DORMANT HIV.
FORM 990, PART VI, LINE 11B	PROCESS USED BY MANAGEMENT AND/OR GOVERNING BODY TO REVIEW FORM 990 THE 990 IS PREPARED BY THE FINANCE DEPARTMENT. IT IS REVIEWED BY THE INSTITUTE'S TAX ADVISORS, SELECTED MEMBERS OF MANAGEMENT INCLUDING THE CFO AND AUDIT COMMITTEE, AND PROVIDED TO MEMBERS OF THE BOARD PRIOR TO FILING.
FORM 990, PART VI, LINE 12C	DESCRIPTION OF PROCESS TO MONITOR TRANSACTIONS FOR CONFLICT OF INTEREST SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE HAS A CONFLICT OF INTEREST POLICY THAT REQUIRES ALL TRUSTEES, PRINCIPAL OFFICERS OR MEMBERS OF A COMMITTEE WITH BOARD DELEGATED POWERS TO ANNUALLY CONFIRM THEIR RECEIPT OF THE CONFLICT OF INTEREST POLICY AND DISCLOSE ANY NEW ASSOCIATIONS OR INTERESTS THAT MIGHT POTENTIALLY POSE A CONFLICT. THIS IS A WRITTEN CONFIRMATION THAT SHE OR HE READ AND UNDERSTANDS THE CONFLICT OF INTEREST POLICY, WILL ABIDE BY THE CONFLICT OF INTEREST POLICY AND CERTIFIES DISCLOSURE OF ALL INTERESTS OR RELATIONSHIPS THAT MAY POSE CONFLICTS. IN ADDITION, EACH YEAR NEW TRUSTEES RECEIVE TRAINING REGARDING THE INSTITUTES CONFLICT OF INTEREST POLICY, WHICH INCLUDES HOW TO IDENTIFY A CONFLICT OF INTEREST AND HOW TO HANDLE POSSIBLE CONFLICTS OF INTEREST WHEN THEY ARISE. THE COMPLIANCE DEPARTMENT REVIEWS EACH OF THE STATEMENTS AND ASSESSES WHETHER AN ACTUAL OR POTENTIAL CONFLICT OF INTEREST EXISTS/MAY EXIST AND WHETHER THE INDIVIDUAL SHOULD BE PROHIBITED FROM CONSIDERATION OF RELATED ITEMS. ANY TRUSTEE, PRINCIPAL OFFICER OR MEMBER OF A COMMITTEE WITH BOARD DELEGATED POWERS WITH A CONFLICT IN A MATTER REQUIRING ACTION BY THE BOARD ARE PROHIBITED FROM PARTICIPATING IN THE BOARDS DELIBERATIONS AND/OR VOTING ON THE PARTICULAR TRANSACTION OR MATTER IN WHICH HE OR SHE HAS AN INTEREST; AND OTHERWISE REFRAIN FROM EXERTING ANY INFLUENCE TO AFFECT A DECISION. HOWEVER, OTHER MEASURES MAY BE REQUIRED, DEPENDING ON THE NATURE OF AND THE ABILITY TO REASONABLY MANAGE A CONFLICT.
FORM 990, PART VI, LINES 15A & 15B	PROCESS FOR DETERMINING COMPENSATION COMPENSATION FOR THE CEO, THE PRESIDENT, CHIEF FINANCIAL OFFICER, AND OTHER KEY EMPLOYEES IS ESTABLISHED ACCORDING TO INSTITUTE POLICIES WHICH ARE DESIGNED TO MEET THE IRS STANDARD FOR "REBUTTABLE PRESUMPTION OF REASONABLENESS". THE COMPENSATION COMMITTEE OF THE BOARD OF TRUSTEES, CONSISTING OF FOUR INDEPENDENT TRUSTEES, REVIEWS COMPARABILITY DATA PROVIDED BY AN INDEPENDENT EXTERNAL CONSULTANT THAT INCORPORATES AND EVALUATES INSTITUTE DATA AND THAT OF COMPARABLE ORGANIZATIONS AND MARKETS FROM WHICH THE INSTITUTE DRAWS ITS EXECUTIVE TALENT. UTILIZING THIS INFORMATION, THE COMPENSATION COMMITTEE, WHICH TYPICALLY SEEKS TO ESTABLISH COMPENSATION BETWEEN THE 50TH AND THE 75TH PERCENTILE OF THE COMPARABILITY DATA, MAKES A DETERMINATION WHETHER THE PROPOSED COMPENSATION IS REASONABLE. THE COMPENSATION COMMITTEE HAS BEEN DELEGATED AUTHORITY BY THE BOARD OF TRUSTEES TO REVIEW AND APPROVE COMPENSATION OF ALL POSITIONS EXCEPT FOR THE CEO. THE CEO'S COMPENSATION PACKAGE IS REVIEWED AND APPROVED INITIALLY BY THE COMPENSATION COMMITTEE AND THEN GOES TO THE EXECUTIVE COMMITTEE FOR FINAL APPROVAL. THE COMPENSATION COMMITTEE CONTEMPORANEOUSLY AND ADEQUATELY DOCUMENTS THE BASIS FOR ITS DETERMINATION AND RECOMMENDATION TO THE EXECUTIVE COMMITTEE. IF APPROVED BY THE EXECUTIVE COMMITTEE, THE CEO COMPENSATION PACKAGE IS THEN IMPLEMENTED AND SUCH DOCUMENTATION IS KEPT IN THE WRITTEN AND ELECTRONIC RECORDS OF THE BOARD OF TRUSTEES. THE PROCESS WAS LAST COMPLETED ON AUGUST 26, 2020 FOR THE FOLLOWING POSITIONS: 1) PRESIDENT 2) CAO/CFO 3) VP BUSINESS DEVELOPMENT 4) VP PHILANTHROPY 5) SVP DRUG DISCOVERY & DEVELOPMENT 6) PROGRAM DIRECTOR/PROFESSOR 7) CANCER CENTER DIRECTOR/PROFESSOR 8) INFECTIOUS & INFLAMMATORY DISEASE CENTER DIRECTOR/PROFESSOR
FORM 990, PART VI, LINE 19	PROCESS FOR MAKING DOCUMENTS AVAILABLE TO THE PUBLIC DOCUMENTS ARE AVAILABLE UPON REQUEST.